Isoray to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 16, 2020

RICHLAND, WASHINGTON  – September 16, 2020 – Isoray, Inc. (NYSE American: ISR)a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23 at 1:40 p.m. ETCEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference. 

A live webcast of the presentation will be available on Isoray’s Investor Relations section of the Company’s website at https://isoray.com/investors/presentations/. An on-demand replay of the presentation will be available shortly after the conclusion of the presentation on the Investor Relations section of the website and will be available for 90 days.  

Contact:  

Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747 

About Isoray 

Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.comFollow us on LinkedIn and Twitter. Join us on Facebook. 

 

Investor Relations:

Mark Levin

Global IR Group
(501) 255-1910

Media and Public Relations:

Sharon Schultz
Schultz Public Relations
(302) 539-3747
schultzpr@mchsi.com

Isoray Announces First Quarter Fiscal 2021 Financial Results

Revenue Increased 3% Year-Over-Year Non-Prostate Brachytherapy Revenue Increased 104% Year-Over-Year RICHLAND, WASHINGTON – November 10, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding...

read more